[{"id":"8e68b197-bc4f-4479-9ecd-61cd7d26dc27","acronym":"MEPI-AGE","url":"https://clinicaltrials.gov/study/NCT06761274","created_at":"2025-02-26T07:31:58.859Z","updated_at":"2025-02-26T07:31:58.859Z","phase":"","brief_title":"Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma","source_id_and_acronym":"NCT06761274 - MEPI-AGE","lead_sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","biomarkers":" KLRG1 • B3GAT1","pipe":"","alterations":" ","tags":["KLRG1 • B3GAT1"],"overall_status":"Recruiting","enrollment":" Enrollment 200","initiation":"Initiation: 11/03/2022","start_date":" 11/03/2022","primary_txt":" Primary completion: 09/30/2025","primary_completion_date":" 09/30/2025","study_txt":" Completion: 09/30/2025","study_completion_date":" 09/30/2025","last_update_posted":"2025-01-07"},{"id":"30aef5c9-4186-4030-80ca-8f512afdcdbc","acronym":"IOSCAR","url":"https://clinicaltrials.gov/study/NCT04624828","created_at":"2021-01-19T20:35:18.695Z","updated_at":"2024-07-02T16:35:56.368Z","phase":"","brief_title":"Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT","source_id_and_acronym":"NCT04624828 - IOSCAR","lead_sponsor":"Istituto Clinico Humanitas","biomarkers":" PD-1 • HAVCR2 • IL2RA • TIGIT • CD36 • CD24 • ENTPD1 • KLRG1 • CEACAM8 • ISG20","pipe":"","alterations":" ","tags":["PD-1 • HAVCR2 • IL2RA • TIGIT • CD36 • CD24 • ENTPD1 • KLRG1 • CEACAM8 • ISG20"],"overall_status":"Recruiting","enrollment":" Enrollment 40","initiation":"Initiation: 10/19/2020","start_date":" 10/19/2020","primary_txt":" Primary completion: 12/01/2023","primary_completion_date":" 12/01/2023","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2023-02-06"},{"id":"e6ba65a5-add8-46e3-92be-e691b36ec343","acronym":"","url":"https://clinicaltrials.gov/study/NCT01426828","created_at":"2021-01-18T05:53:17.271Z","updated_at":"2024-07-02T16:36:37.817Z","phase":"Phase 2","brief_title":"Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant","source_id_and_acronym":"NCT01426828","lead_sponsor":"University of Pennsylvania","biomarkers":" CD8 • CD4 • TBX21 • KLRG1","pipe":"","alterations":" ","tags":["CD8 • CD4 • TBX21 • KLRG1"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 08/01/2011","start_date":" 08/01/2011","primary_txt":" Primary completion: 06/01/2016","primary_completion_date":" 06/01/2016","study_txt":" Completion: 12/01/2017","study_completion_date":" 12/01/2017","last_update_posted":"2020-12-04"}]